Literature DB >> 15110888

Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?--a population-based study.

L H Christensen1, G Engholm, J Ceberg, S Hein, R Perfekt, U B Tange, M Andersson, H T Mouridsen, T Möller, H H Storm.   

Abstract

Analyses of data from cancer registries have shown a 10% unit difference in 5-year relative survival between Danish and Swedish patients with breast cancer. This study investigates the effect of age and patho-anatomic variables on this survival difference. Hospital records were collected for women over 40 years of age diagnosed in 1989 or 1994 in east Denmark and south Sweden; patho-anatomical variables and survival were compared between 2289 Danish and 1715 Swedish women. Tumours were smaller, node-negative axillae more frequent and well-differentiated tumours almost 10% more frequent in Sweden. A superior 5-year relative survival in Sweden was found in the 50- to 79-year age group. The adjusted hazard rate ratio between countries was 1.7 in 1989 and 1.3 in 1994. Conditional survival after surviving the first 5 years was similar for the two countries. Adjusting for patho-anatomical variables reduced but did not eliminate the higher risk of death among the Danish patients. Higher population death rates could explain some but not all of the residual elevated risk for Danish women.

Entities:  

Mesh:

Year:  2004        PMID: 15110888     DOI: 10.1016/j.ejca.2004.01.005

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study.

Authors:  Lauren C Harshman; Wanling Xie; Georg A Bjarnason; Jennifer J Knox; Mary MacKenzie; Lori Wood; Sandy Srinivas; Ulka N Vaishampayan; Min-Han Tan; Sun-Young Rha; Frede Donskov; Neeraj Agarwal; Christian Kollmannsberger; Scott North; Brian I Rini; Daniel Y C Heng; Toni K Choueiri
Journal:  Lancet Oncol       Date:  2012-08-08       Impact factor: 41.316

2.  Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07.

Authors:  Beth A Zamboni; Greg Yothers; Mehee Choi; Clifton D Fuller; James J Dignam; Peter C Raich; Charles R Thomas; Michael J O'Connell; Norman Wolmark; Samuel J Wang
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

3.  Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.

Authors:  S Walters; C Maringe; J Butler; B Rachet; P Barrett-Lee; J Bergh; J Boyages; P Christiansen; M Lee; F Wärnberg; C Allemani; G Engholm; T Fornander; M L Gjerstorff; T B Johannesen; G Lawrence; C E McGahan; R Middleton; J Steward; E Tracey; D Turner; M A Richards; M P Coleman
Journal:  Br J Cancer       Date:  2013-02-28       Impact factor: 7.640

4.  Conditional survival of cancer patients: an Australian perspective.

Authors:  Xue Qin Yu; Peter D Baade; Dianne L O'Connell
Journal:  BMC Cancer       Date:  2012-10-08       Impact factor: 4.430

5.  Prognostic factors for conditional survival in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy.

Authors:  Minyong Kang; Hyung Suk Kim; Chang Wook Jeong; Choel Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Sci Rep       Date:  2015-07-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.